Status:
COMPLETED
Arthroplasty and Modifiable Risk Factors
Lead Sponsor:
Landspitali University Hospital
Conditions:
Total Joint Arthroplasty
Risk Reduction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hip and knee total joint arthroplasty are one of the most frequently performed surgery worldwide. However, prosthetic joint infection remains a devastating complication of them, associated with severe...
Detailed Description
Hip and knee total joint arthroplasty allow effective treatment of disability and pain due to joint destruction, and are one of the most frequently performed surgery worldwide. Surgical-site infection...
Eligibility Criteria
Inclusion
- All adult patients undergoing elective primary arthroplasty of either hip or knee at Landspitali University Hospital
Exclusion
- Contraindications for operation detected after inclusion. Patients having an operation on another joint within the inclusion period were not re-included.
Key Trial Info
Start Date :
August 20 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
1484 Patients enrolled
Trial Details
Trial ID
NCT05399186
Start Date
August 20 2018
End Date
December 31 2022
Last Update
October 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Landspitali University Hsopital
Reykjavik, Hringbraut, Iceland, 108